This inventor holds 3 USPTO granted patents. Top assignee: Tularik Limited. Active years: 1997-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Francisco, CA (US) (1997)
- San Bruno, CA (US) (2001 - 2004)
Company Filing History:
Years Active: 1997-2004
Title: The Innovations of Pengguang Wu
Introduction
Pengguang Wu is a notable inventor based in San Bruno, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of high-throughput screening assays. With a total of 3 patents to his name, Wu's work has the potential to impact various therapeutic areas.
Latest Patents
Wu's latest patents include innovative methods for modulating the activity of STAT4 and STAT6 polypeptides. One of his inventions, titled "High-throughput screening assays for modulators of STAT4 activity," provides receptor peptides that exhibit a high affinity for STAT4 and STAT6 polypeptides. This invention also includes assays that are useful for identifying compounds that can modulate the interaction between these polypeptides and their respective cellular promoters. The assays are designed to be amenable to high-throughput screening, facilitating the discovery of new therapeutic agents.
Another patent, "High-throughput screening assays for modulators of STAT4 and STAT6 activity," shares similar features and aims to enhance the understanding of these critical signaling pathways. These inventions highlight Wu's commitment to advancing scientific knowledge and improving healthcare outcomes.
Career Highlights
Pengguang Wu is currently associated with Tularik Limited, where he continues to innovate and contribute to the field. His work at Tularik Limited has positioned him as a key player in the biotechnology sector, focusing on the development of novel therapeutic strategies.
Collaborations
Wu collaborates with talented professionals in his field, including colleagues such as Judi McKinney and Kelly Lamarco. These collaborations enhance the research environment and foster innovation within the company.
Conclusion
Pengguang Wu's contributions to biotechnology through his patents and work at Tularik Limited demonstrate his dedication to advancing medical science. His innovative approaches to high-throughput screening assays are paving the way for new therapeutic discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile